115 related articles for article (PubMed ID: 16965276)
1. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
Wakamatsu K; Ito S
Pigment Cell Res; 2006 Oct; 19(5):460-4. PubMed ID: 16965276
[TBL] [Abstract][Full Text] [Related]
2. Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese.
Wakamatsu K; Ito S
Pigment Cell Res; 1995 Jun; 8(3):132-4. PubMed ID: 7567788
[TBL] [Abstract][Full Text] [Related]
3. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1990; 70(5):367-72. PubMed ID: 1980967
[TBL] [Abstract][Full Text] [Related]
4. Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation.
Wolber R; Schlenz K; Wakamatsu K; Smuda C; Nakanishi Y; Hearing VJ; Ito S
Pigment Cell Melanoma Res; 2008 Aug; 21(4):487-91. PubMed ID: 18627527
[TBL] [Abstract][Full Text] [Related]
5. Serum 5-S-cysteinyldopa levels in patients with psoriasis undergoing narrowband ultraviolet B phototherapy.
Kikuchi K; Wakamatsu K; Tada Y; Komine M; Ito S; Tamaki K
Clin Exp Dermatol; 2008 Nov; 33(6):750-3. PubMed ID: 18954414
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
Meyerhöffer S; Lindberg Z; Häger A; Kågedal B; Rosdahl I
Acta Derm Venereol; 1998 Jan; 78(1):31-5. PubMed ID: 9498023
[TBL] [Abstract][Full Text] [Related]
7. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
Wakamatsu K; Ito S; Horikoshi T
Melanoma Res; 1991; 1(2):141-7. PubMed ID: 1823626
[TBL] [Abstract][Full Text] [Related]
8. Determination of eumelanin in human urine.
Wakamatsu K; Takasaki A; Kågedal B; Kageshita T; Ito S
Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
[TBL] [Abstract][Full Text] [Related]
9. The stability of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in human urine.
Kågedal B; Lenner L; Arstrand K; Hansson C
Pigment Cell Res; 1992; Suppl 2():304-7. PubMed ID: 1409435
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of melanin-related metabolites as markers of melanoma progression.
Horikoshi T; Ito S; Wakamatsu K; Onodera H; Eguchi H
Cancer; 1994 Feb; 73(3):629-36. PubMed ID: 8299084
[TBL] [Abstract][Full Text] [Related]
11. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma.
Hara H; Walsh N; Yamada K; Jimbow K
J Invest Dermatol; 1994 Apr; 102(4):501-5. PubMed ID: 8151128
[TBL] [Abstract][Full Text] [Related]
12. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
Wakamatsu K; Ito S; Fujita K
Acta Derm Venereol; 1988; 68(5):385-9. PubMed ID: 2461020
[TBL] [Abstract][Full Text] [Related]
13. Biochemical observations in UV-induced pigmentation.
Rorsman H; Tegner E
Photodermatol; 1988 Feb; 5(1):30-8. PubMed ID: 3281148
[TBL] [Abstract][Full Text] [Related]
14. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
Saito N; Morishima T
Nihon Hifuka Gakkai Zasshi; 1990 Jul; 100(8):853-61. PubMed ID: 2122048
[TBL] [Abstract][Full Text] [Related]
15. Melanocyte metabolites in the urine of people of different skin colour.
Wirestrand LE; Hansson C; Rosengren E; Rorsman H
Acta Derm Venereol; 1985; 65(4):345-8. PubMed ID: 2413694
[TBL] [Abstract][Full Text] [Related]
16. Some indolic compounds as markers of the melanocyte activity.
Hansson C
Acta Derm Venereol Suppl (Stockh); 1988; 138():1-60. PubMed ID: 3176811
[TBL] [Abstract][Full Text] [Related]
17. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
Yamada K; Walsh N; Hara H; Jimbow K; Chen H; Ito S
Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
[TBL] [Abstract][Full Text] [Related]
18. Serum 5-S-cysteinyldopa (5-S-CD) as a marker of melanoma progression.
Horikoshi T; Ito S
J Dermatol; 1992 Nov; 19(11):809-13. PubMed ID: 1293168
[TBL] [Abstract][Full Text] [Related]
19. 5-S-cysteinyldopa and pigment response to UVA light.
Tegner E; Rorsman H; Rosengren E
Acta Derm Venereol; 1983; 63(1):21-5. PubMed ID: 6191484
[TBL] [Abstract][Full Text] [Related]
20. Plasma 5-S-cysteinyldopa as an index of melanogenesis.
Nimmo JE; Gawkrodger DJ; O'Docherty CS; Going SM; Percy-Robb IW; Hunter JA
Br J Dermatol; 1988 Apr; 118(4):487-95. PubMed ID: 3132198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
